NCT03155022

Brief Summary

Infarct size is a major determinant of prognosis after AMI. Evidence indicates that the combination of intracoronary ischemic conditioning (ICIC) and remote ischemic conditioning (RIC) can significantly reduce infarct size in STEMI patients. Whether the combination of these two interventions may improve clinical outcome after STEMI remains unknown. The objective of the present study is to determine whether combination of ICIC and RIC can improve STEMI patients clinical outcome at 6 months.

Trial Health

90
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
750

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Apr 2018

Longer than P75 for not_applicable

Geographic Reach
2 countries

4 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 11, 2017

Completed
5 days until next milestone

First Posted

Study publicly available on registry

May 16, 2017

Completed
11 months until next milestone

Study Start

First participant enrolled

April 12, 2018

Completed
5.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 3, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 3, 2023

Completed
Last Updated

August 28, 2025

Status Verified

August 1, 2025

Enrollment Period

5.5 years

First QC Date

May 11, 2017

Last Update Submit

August 27, 2025

Conditions

Keywords

ST-elevation myocardial infarction

Outcome Measures

Primary Outcomes (1)

  • Combined incidence of [all-cause mortality; worsening of heart failure during initial hospitalization or re-hospitalization for heart failure at 6 months after MI, large infarct defined as CK peak at 6 hours > 4500 UI/L]

    6 months

Secondary Outcomes (9)

  • Cardiovascular death at 6 months.

    6 months

  • Worsening of heart failure

    6 months

  • Time to first event [all-cause mortality; worsening of heart failure during initial hospitalization or re-hospitalization for heart failure]

    6 months

  • Major Adverse Cardiac Events (MACE)

    6 months

  • Renal failure

    6 months

  • +4 more secondary outcomes

Study Arms (2)

RIC+ ICIC +

EXPERIMENTAL

Patients with remote ischemic conditioning and intracoronary ischemic conditioning

Device: Remote ischemic conditioning and intracoronary ischemic conditioning

RCI - ICIC -

OTHER

Control group with no remote ischemic conditioning and no intracoronary ischemic conditioning

Device: Patients with no remote ischemic conditioning and no intracoronary ischemic conditioning

Interventions

RIC: Four cycles of \[5 min brachial cuff inflation at 200 mmHg followed by 5 min of cuff deflation\] started as soon as possible prior to PCI reperfusion. At least one full cycle (inflation + deflation) has to be completed before PCI reperfusion. ICIC: Four cycles of \[1 min balloon inflation followed by 1 min balloon deflation\] started as soon as possible after reopening of the culprit coronary artery (maximum within 3 minutes after reflow). The balloon will be placed carefully above the culprit lesion so as to minimize potential micro-embolization.

RIC+ ICIC +

Brachial cuff is positioned during 40 minutes but not inflated. No intracoronary balloon inflation.

RCI - ICIC -

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • All (male and female) patients, aged over 18,
  • Presenting within 12 hours of the onset of chest pain,
  • For whom the clinical decision was made to treat with percutaneous coronary intervention (PCI),
  • ST segment elevation ≥ 0.2 mV in two contiguous ECG leads,
  • Written informed consent obtained or oral informed consent certified by a third party.
  • Patients with cardiogenic shock,
  • Patients with uncontrolled (treated or untreated) hypertension (\> 180/110 mmHg),
  • Patients with loss of consciousness or confused,
  • Patients without health coverage,
  • Patient with any legal protection measure,
  • Female patients currently pregnant (oral diagnosis) or women of childbearing age who were not using contraception.

You may not qualify if:

  • Patients with main occlusion localized on :
  • LAD: distal or ostial segment,
  • Non dominant RCA / CX: mid or distal segment,
  • Dominant RCA / CX: distal segment,
  • Any other arteries apart LAD/CX/RCA; Patients with evidence of coronary collaterals to the risk region (Rentrop score ≥ 2); Patients with an opened (TIMI \> 1) culprit coronary artery on initial admission coronary angiography or a failed PCI (final TIMI=0).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (4)

Algemeen Ziekenhuis Sint Jan

Bruges, Belgium

Location

CHU de Charleroi

Charleroi, Belgium

Location

Universitair Ziekenhuis Antwerpen

Edegem, Belgium

Location

Hopital Louis Pradel

Bron, France

Location

MeSH Terms

Conditions

Myocardial InfarctionST Elevation Myocardial Infarction

Condition Hierarchy (Ancestors)

Myocardial IschemiaHeart DiseasesCardiovascular DiseasesVascular DiseasesInfarctionIschemiaPathologic ProcessesPathological Conditions, Signs and SymptomsNecrosis

Study Officials

  • Gilles Rioufol, Pr

    Hôpital Louis Pradel 28 avenue Doyen Lépine, BP Lyon-Montchat, 69394LYON cedex 03

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 11, 2017

First Posted

May 16, 2017

Study Start

April 12, 2018

Primary Completion

October 3, 2023

Study Completion

October 3, 2023

Last Updated

August 28, 2025

Record last verified: 2025-08

Locations